Peel Hunt reaffirmed their buy rating on shares of Udg Healthcare (LON:UDG) in a report published on Thursday, ThisIsMoney.Co.Uk reports.
Several other equities research analysts also recently weighed in on the stock. Royal Bank of Canada downgraded shares of Udg Healthcare to a sector performer rating and reduced their target price for the company from GBX 830 ($10.85) to GBX 800 ($10.45) in a research note on Monday, August 12th. Liberum Capital reaffirmed a buy rating on shares of Udg Healthcare in a research note on Tuesday, November 26th. Berenberg Bank lifted their price target on shares of Udg Healthcare from GBX 700 ($9.15) to GBX 850 ($11.11) and gave the stock a hold rating in a research note on Tuesday, August 20th. Finally, Barclays reiterated an overweight rating and set a GBX 830 ($10.85) price target on shares of Udg Healthcare in a report on Thursday, November 21st. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company has a consensus rating of Hold and a consensus target price of GBX 858.17 ($11.21).
LON UDG opened at GBX 805 ($10.52) on Thursday. The company has a quick ratio of 1.50, a current ratio of 1.59 and a debt-to-equity ratio of 26.65. Udg Healthcare has a 52 week low of GBX 545 ($7.12) and a 52 week high of GBX 846 ($11.05). The firm has a market capitalization of $2.01 billion and a price-to-earnings ratio of 35.15. The company has a fifty day moving average of GBX 780.40 and a two-hundred day moving average of GBX 762.21.
Udg Healthcare Company Profile
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.